203 related articles for article (PubMed ID: 38128727)
1. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
[TBL] [Abstract][Full Text] [Related]
2. [Key microbial monitoring and clinical analysis of bloodstream infections and CRO colonization after hematopoietic stem cell transplantation in hematological patients].
Zhang A; Qian CJ; Wei RW; Jiang S; Fang J; Shi W; Xia LH
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):134-140. PubMed ID: 38604789
[No Abstract] [Full Text] [Related]
3. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Clerici D; Oltolini C; Greco R; Ripa M; Giglio F; Mastaglio S; Lorentino F; Pavesi F; Farina F; Liberatore C; Castiglion B; Tassan Din C; Bernardi M; Corti C; Peccatori J; Scarpellini P; Ciceri F; Castagna A
Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
Nirmal G; Jithin TK; Gopakumar KG; Parthiban R; Nair C
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e678-e682. PubMed ID: 37146155
[TBL] [Abstract][Full Text] [Related]
5. Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network).
Falcone M; Tiseo G; Carbonara S; Marino A; Di Caprio G; Carretta A; Mularoni A; Mariani MF; Maraolo AE; Scotto R; Dalfino L; Corbo L; Macera M; Medaglia AA; d'Errico ML; Gioè C; Sgroi C; Del Vecchio RF; Ceccarelli G; Albanese A; Buscemi C; Talamanca S; Raponi G; Foti G; De Stefano G; Franco A; Iacobello C; Corrao S; Morana U; Pieralli F; Gentile I; Santantonio T; Cascio A; Coppola N; Cacopardo B; Farcomeni A; Venditti M; Menichetti F;
Clin Infect Dis; 2023 Jun; 76(12):2059-2069. PubMed ID: 36801828
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study.
Zhuang HH; Chen Y; Hu Q; Long WM; Wu XL; Wang Q; Xu TT; Qu Q; Liu YP; Xiao YW; Qu J
J Infect Public Health; 2023 Jun; 16(6):938-947. PubMed ID: 37087853
[TBL] [Abstract][Full Text] [Related]
7. Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia.
Cheng S; Fleres G; Chen L; Liu G; Hao B; Newbrough A; Driscoll E; Shields RK; Squires KM; Chu TY; Kreiswirth BN; Nguyen MH; Clancy CJ
mBio; 2022 Dec; 13(6):e0290622. PubMed ID: 36445082
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Bandy A; Almaeen AH
PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant
Chen Y; Huang HB; Peng JM; Weng L; Du B
Microbiol Spectr; 2022 Apr; 10(2):e0260321. PubMed ID: 35377233
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
[TBL] [Abstract][Full Text] [Related]
12. Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters".
Lodise TP; Kanakamedala H; Hsu WC; Cai B
Pharmacotherapy; 2020 Sep; 40(9):889-901. PubMed ID: 33112456
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream Infections due to Carbapenem-Resistant
Shen L; Lian C; Zhu B; Yao Y; Yang Q; Zhou J; Zhou H
Microb Drug Resist; 2021 Feb; 27(2):227-233. PubMed ID: 32584202
[TBL] [Abstract][Full Text] [Related]
14. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
Yang S; Xu H; Sun J; Sun S
Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
[TBL] [Abstract][Full Text] [Related]
15. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Shah PG; Shah SR
J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
[TBL] [Abstract][Full Text] [Related]
16. Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
Giacobbe DR; Marelli C; Cattardico G; Fanelli C; Signori A; Di Meco G; Di Pilato V; Mikulska M; Mazzitelli M; Cattelan AM; Pallotto C; Francisci D; Calabresi A; Lombardi A; Gori A; Del Bono V; Aldieri C; Losito AR; Raffaelli F; Cortegiani A; Milazzo M; Del Puente F; Pontali E; De Rosa FG; Corcione S; Mularoni A; Russelli G; Giacomini M; Badalucco Ciotta F; Oltolini C; Serino FS; Momesso E; Spinicci M; Graziani L; Torti C; Trecarichi EM; Merli M; D'Amico F; Marchese A; Vena A; Bassetti M
J Antimicrob Chemother; 2023 Oct; 78(10):2505-2514. PubMed ID: 37606528
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
[TBL] [Abstract][Full Text] [Related]
18. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.
Giannella M; Trecarichi EM; De Rosa FG; Del Bono V; Bassetti M; Lewis RE; Losito AR; Corcione S; Saffioti C; Bartoletti M; Maiuro G; Cardellino CS; Tedeschi S; Cauda R; Viscoli C; Viale P; Tumbarello M
Clin Microbiol Infect; 2014 Dec; 20(12):1357-62. PubMed ID: 24980276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
